EBMT 2017

Concerns about using social media in oncology

Predicting and preventing clonal evolution in multiple myeloma

Only the beginning of precision medicine and multiple myeloma.

Autologous stem cell transplantations: BEAM or BEAC?

Updates on treatment methods for Hodgkin Lymphoma

Cellular therapy: a key part of EBMT 2017

Advantages of chemotherapy and hypomethylating agents in myelodysplastic syndrome

Allogeneic transplant is not the quintessential treatment for ALL anymore!

Treatment methods in mantle cell lymphoma

What are the differences in health technology assessment (HTA) across Europe?

How can clinicians and nurses care for patients with oral graft-versus-host disease (GvHD)?

Transplantation versus novel therapies in high-risk chronic lymphoblastic leukemia (CLL)?

Can the cytomegalovirus be predicted by ELISpot assays?

Highlights from the EBMT 2017 cell therapy day

Waldenström’s macroglobulinemia: Treatment methods and clonal evolution

Is double autologous transplantation in multiple myeloma superior in the age of new agents?